Acadia Healthcare Company, a prominent player in the behavioral healthcare sector, has recently announced the appointment of Wade D. Miquelon to its board of directors. With an extensive background in finance and executive leadership, Miquelon’s addition is expected to enhance Acadia’s strategic direction, particularly as the company continues to navigate the complexities of the healthcare market.
Wade D. Miquelon is not a newcomer to the corporate world, having amassed a wealth of experience in various high-level roles across multiple industries. Since January 2012, Miquelon has served as a director at Acadia, bringing with him a robust financial acumen developed through his previous positions. Currently, he holds the prestigious title of President and Chief Executive Officer of Jo-Ann Stores, LLC, which is recognized as the leading fabric and craft specialty retailer in the United States.
Prior to his tenure at Jo-Ann Stores, Miquelon made significant contributions to Walgreens, where he served as Executive Vice President, President International, and Chief Financial Officer until August 2014. His journey with Walgreens began in June 2008 when he joined as Senior Vice President and Chief Financial Officer. During his time at Walgreens, Miquelon was instrumental in implementing financial strategies that bolstered the company’s performance.
Before his impactful role at Walgreens, Miquelon was the Executive Vice President and Chief Financial Officer at Tyson Foods, Inc. from 2006 to 2008. His career also includes a notable 17-year tenure at Procter & Gamble Co. (P&G), where he held various positions of increasing responsibility. Most recently, he served as Vice President of Finance for Western Europe, overseeing financial operations across 17 countries. His multifaceted experience at P&G included leadership roles in finance and accounting across multiple regions, showcasing his ability to drive financial performance on a global scale.
Miquelon’s election to Acadia’s board reflects the company’s strategic intent to leverage his diverse expertise in finance and operational management. Joey Jacobs, chairman and CEO of Acadia, expressed confidence in Miquelon’s ability to contribute to the company’s long-term growth, emphasizing the value of having someone with his level of experience in both established and emerging markets.
Under Miquelon’s financial stewardship, Acadia is poised for continued growth. Since being listed on the Nasdaq, the company has seen its shares climb 20 percent, culminating in a market valuation of over $300 million. This trajectory indicates a strong demand for Acadia’s services and a growing recognition of its commitment to delivering quality behavioral healthcare.
As Acadia Healthcare expands its board to include Wade D. Miquelon, the company is not only enhancing its governance structure but also reinforcing its commitment to long-term shareholder value. Miquelon’s strategic insights will be vital as Acadia continues to explore new opportunities within the ever-evolving healthcare landscape.
In conclusion, the appointment of Wade D. Miquelon to the Acadia Healthcare board is a significant move aimed at bolstering the company’s financial leadership. With a proven track record in both established corporations and growth-focused entities, Miquelon’s experience is expected to play a critical role in navigating the challenges and opportunities that lie ahead for Acadia Healthcare.